Most Read Articles
Stephen Padilla, 09 Nov 2020
Tocilizumab (TCZ) therapy appears to be effective in patients at risk of cytokine release syndrome (CRS) from the novel coronavirus disease (COVID-19), suggests a study presented at ID Week 2020. Those receiving TCZ in a nonintensive care unit (non-ICU) setting show better response than ICU patients.
Stephen Padilla, 10 Nov 2020
Patients with chronic obstructive pulmonary disease (COPD) seem to benefit from using chlorhexidine oral rinses twice daily as shown by the reduction in oral and sputum microbiota alpha diversity and by clinically significant improvements in COPD symptoms, according to a study presented at ID Week 2020.
Rachel Soon, 28 Aug 2020
MOH Director-General Tan Sri Dato' Seri Dr Noor Hisham Abdullah speaks about NHMS 2019 and pharmacists' roles in combating NCDs among Malaysians.

Chemoradiation enables resection in patients with locally advanced pancreatic cancer

18 Nov 2020

Neoadjuvant chemoradiation facilitates subsequent surgical resection in patients with locally advanced pancreatic cancer (LAPC), which helps to substantially prolong survival, a study has found.

“Therefore, surgical exploration should be offered if vessel involvement is improved by chemoradiation and considered in radiographic unchanged vessel involvement if size and cancer antigen (CA) 19.9 levels decrease, as these factors may indicate resectable disease, too,” the authors said.

Forty-nine patients with unresectable LAPC underwent contouring of their pancreatic gross tumour and all major abdominal vessels before and after neoadjuvant chemoradiation. Paired t tests were carried out to compare changes. Finally, the authors used the Medical Imaging Interaction Toolkit to quantify tumour-vessel relationships, which were then examined for association with resectability and outcome.

Chemoradiation substantially reduced tumour volumes from 41 to 33 mL (p<0.0001). For majority of the patients, maximum circumferential vessel involvement decreased and was statistically significant for the superior mesenteric (p<0.003) and splenic veins (p<0.038).

Resection was possible in some patients, which resulted in prolonged survival (28 vs 15 mo; r, 0.40), a decrease in CA 19.9 levels (r, 0.48), and reduced involvement of most vessels.

Other patients who did not show improvement in radiographic vessel involvement, but rather a decrease in tumour volume and CA 19.9 levels, also achieved surgical resection with a successful detachment of tumour tissue from major vessels.

“Survival of patients with LAPC is improved when neoadjuvant chemoradiation enables subsequent surgical resection,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 09 Nov 2020
Tocilizumab (TCZ) therapy appears to be effective in patients at risk of cytokine release syndrome (CRS) from the novel coronavirus disease (COVID-19), suggests a study presented at ID Week 2020. Those receiving TCZ in a nonintensive care unit (non-ICU) setting show better response than ICU patients.
Stephen Padilla, 10 Nov 2020
Patients with chronic obstructive pulmonary disease (COPD) seem to benefit from using chlorhexidine oral rinses twice daily as shown by the reduction in oral and sputum microbiota alpha diversity and by clinically significant improvements in COPD symptoms, according to a study presented at ID Week 2020.
Rachel Soon, 28 Aug 2020
MOH Director-General Tan Sri Dato' Seri Dr Noor Hisham Abdullah speaks about NHMS 2019 and pharmacists' roles in combating NCDs among Malaysians.